We are live on ! Find out more
Lord, Abbett & Co

Lord, Abbett & Co Portfolio holdings

AUM $30.6B
1-Year Est. Return 57.44%
This Fund
S&P 500
This Quarter Est. Return
+13.24%
1 Year Est. Return
+57.44%
3 Year Est. Return
+215.76%
5 Year Est. Return
+368.6%
10 Year Est. Return
+2,376.62%
AUM
$43.9B
AUM Growth
+$2.09B
Cap. Flow
-$3.3B
Cap. Flow %
-7.52%
Top 10 Hldgs %
15.27%
Holding
715
New
81
Increased
209
Reduced
224
Closed
119

Sector Composition

Rank Sector Weight
1 Technology 24.76%
2 Healthcare 13.4%
3 Financials 12.39%
4 Consumer Discretionary 11.57%
5 Industrials 11.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PIPR icon
176
Piper Sandler
PIPR
$4.99B
$76.4M 0.17%
1,711,824
+1,233,580
+258% +$52.4M
FOXF icon
177
Fox Factory Holding Corp
FOXF
$794M
$76.2M 0.17%
447,975
+10,672
+2% +$1.79M
FFIV icon
178
F5
FFIV
$22B
$75.8M 0.17%
309,957
+174,547
+129% +$38.7M
RUSHA icon
179
Rush Enterprises Class A
RUSHA
$6.34B
$75.4M 0.17%
2,032,372
-406,413
-17% -$14.2M
CB icon
180
Chubb
CB
$140B
$75.4M 0.17%
389,800
-4,900
-1% -$920K
AMN icon
181
AMN Healthcare
AMN
$1.35B
$74.7M 0.17%
610,896
+320,207
+110% +$35.5M
CUBE icon
182
CubeSmart
CUBE
$9.61B
$74.6M 0.17%
+1,310,000
New +$70.4M
ABNB icon
183
Airbnb
ABNB
$90.8B
$74M 0.17%
444,424
-527,995
-54% -$93M
SPGI icon
184
S&P Global
SPGI
$124B
$73.7M 0.17%
156,100
+14,400
+10% +$6.59M
MRTX
185
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$73M 0.17%
497,440
+23,349
+5% +$3.63M
COIN icon
186
Coinbase
COIN
$42.2B
$72.9M 0.17%
+288,927
New +$84M
BURL icon
187
Burlington
BURL
$23.4B
$72.7M 0.17%
249,246
-1,277
-0.5% -$359K
SRPT icon
188
Sarepta Therapeutics
SRPT
$1.64B
$72.5M 0.17%
+804,980
New +$68.8M
TNDM icon
189
Tandem Diabetes Care
TNDM
$1.27B
$72.2M 0.16%
+479,965
New +$64.8M
TSCO icon
190
Tractor Supply
TSCO
$16.3B
$71.5M 0.16%
1,498,715
+1,150,005
+330% +$50.3M
CSX icon
191
CSX Corp
CSX
$94B
$70.8M 0.16%
+1,882,802
New +$66.4M
AXTA icon
192
Axalta
AXTA
$7.45B
$70.4M 0.16%
2,124,323
+10,203
+0.5% +$324K
RBLX icon
193
Roblox
RBLX
$35.9B
$69.9M 0.16%
+677,368
New +$65.8M
VMC icon
194
Vulcan Materials
VMC
$36.8B
$69.8M 0.16%
336,111
+135,749
+68% +$26.3M
CRTO icon
195
Criteo S.A. Ordinary Shares
CRTO
$1.14B
$69.7M 0.16%
1,793,088
+14,321
+0.8% +$550K
LMT icon
196
Lockheed Martin
LMT
$131B
$69.3M 0.16%
194,924
-5,497
-3% -$1.9M
DOOR
197
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
$69.2M 0.16%
586,469
+4,053
+0.7% +$464K
ALGN icon
198
Align Technology
ALGN
$12.9B
$68.9M 0.16%
104,884
-166,636
-61% -$107M
ZIP icon
199
ZipRecruiter
ZIP
$339M
$68.5M 0.16%
2,744,581
+1,511,739
+123% +$41.5M
ALLY icon
200
Ally Financial
ALLY
$13.1B
$67.7M 0.15%
1,422,900
-1,208,858
-46% -$59.9M

Similar funds

Lord, Abbett & Co's Q4 2021 Portfolio in Review

As of Q4 2021, Lord, Abbett & Co held 715 positions worth $43.9B, up 5% from $41.8B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Lord, Abbett & Co withdrew a net $3.3B in Q4 2021, closing 119 positions and reducing 224 holdings. Its most notable exit was Snap, an estimated $291M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Lord, Abbett & Co opened a new position in Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A worth $257M.

  • Lord, Abbett & Co's largest Q4 2021 buy was Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A: 117,267 shares worth $257M.
  • Lord, Abbett & Co added most to Pfizer in Q4 2021, an estimated $254M increase.
  • Lord, Abbett & Co's biggest Q4 2021 reduction was Meta Platforms (Facebook), cutting an estimated $289M.
  • Lord, Abbett & Co fully exited Snap in Q4 2021, selling an estimated $291M.
  • Lord, Abbett & Co's ten largest holdings make up 15% of its $43.9B portfolio in Q4 2021.
  • Lord, Abbett & Co opened 81 new positions and closed 119 in Q4 2021.
  • Lord, Abbett & Co's portfolio value rose 5% quarter-over-quarter to $43.9B.

Based on Lord, Abbett & Co's 13F filing for Q4 2021, filed 11 Feb 2022.